Home » Promethera Biosciences Successfully Enrolls Twenty Patients in its Multicentric Phase I
Promethera Biosciences Successfully Enrolls Twenty Patients in its Multicentric Phase I
Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating 20 patients affected by very rare liver-based metabolic diseases.
FirstWord MedTech
FirstWord MedTech
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May